相关实验视频

Updated: May 20, 2025

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

对神经内分泌瘤诊断PET标记物的研究过程

Xiangyuan Bao^1,2, Shuai Li¹, Shaobo Yao^1,2

¹Department of PET/CT Diagnostic, Tianjin Key Lab of Functional Imaging and Tianjin Institute of Radiology, Tianjin Medical University General Hospital Tianjin 300052, China.

American journal of nuclear medicine and molecular imaging

|March 24, 2025

概括

新的放射性追踪剂可以改善神经内分泌瘤 (NET) 诊断和预后预测. 先进的成像技术,如双标志物PET/CT和新的同位素,为各种NET类型提供了卓越的检测和表征.

科学领域:

核医学就是核医学.
在瘤学瘤学.
放射化学放射化学是指辐射化学.

背景情况:

神经内分泌瘤 (NETs) 呈现出多种不同的症状,并且很难通过传统诊断来诊断.
在NET细胞上体静止素受体 (SSTR) 表达是关键的诊断标.
目前的临床诊断很大程度上依赖于标记为[68Ga]的体静止素类似物 (SSA) PET/CT.

研究的目的:

在NET诊断中审查传统和新型放射性追踪器应用.
评估各种成像技术和同位素的性能,用于NET检测和表征.
讨论用于NET管理的不同无线电追踪器的优点和局限性.

主要方法:

对用于NET诊断的传统成像技术的审查.
分析新型放射性追踪剂的临床应用,包括双追踪剂策略 (Ga-SSAs+FDG) 和新同位素 (Cu-SSAs,Ga-Pentixafor,F-MFBG,F-DOPA).
使用评分系统整合成像结果,如NETPET评分用于治疗反应和预后预测.

主要成果:

双追踪器PET/CT ([⁶⁸Ga]Ga-SSAs + [¹⁸F]FDG) 增强了对瘤代谢和受体表达的评估.
新型同位素 ([¹⁸F]/[⁶⁴Cu]) 被标记为SSAs和对抗剂,与[⁶⁸Ga]-SSAs相比,显示出改善的病变检测和瘤与背景比率.
[⁶⁸Ga]Ga-Pentixafor和[¹⁸F]-FDG PET/CT对SSTR阴性NETs是有效的.
[18F]-MFBG和[18F]-DOPA对体红细胞瘤和骨瘤 (PPGL) 具有高度敏感性.

结论:

使用新型射线追踪器的先进PET/CT成像显著提高了NET诊断的准确性.
NETPET评分有助于预测治疗反应和患者的预后.
针对不同的NET亚型,包括SSTR阴性和PPGL等特定类型,量身定制的放射追踪器选择至关重要.

关键词:

聚乙烯/聚乙烯/聚乙烯索马托斯坦的受体是什么?神经内分泌瘤的神经内分泌瘤无线电追踪器是一种无线电追踪器.

更多相关视频

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...